TABLE 1

Patient demographics

Total groupDiabetic groupNondiabetic groupP for diabetic vs. nondiabetic
n1203090
Age (years)65 ± 1064 ± 965 ± 110.65
Sex and ethnicity
    Male80 (70)18 (60)62 (69)0.37
    Caucasian79 (69)22 (73)57 (63)0.32
Weight (lbs)196 ± 51210 ± 55190 ± 510.07
Risk factors/past medical history
    Smoking (previous or current)46 (40)12 (40)34 (38)0.85
    Family history of CAD40 (35)13 (43)27 (30)0.19
    Hypertension73 (64)22 (73)51 (57)0.12
    Hyperlipidemia100 (87)26 (87)74 (82)0.52
    Prior myocardial infarction25 (22)6 (20)19 (21)0.91
    Prior CABG36 (32)9 (30)27 (30)1.00
    Prior PTCA39 (34)10 (33)29 (32)0.91
    Prior CVA6 (5)5 (17)1 (1)0.007
Baseline medications
    β-Blockers69 (61)18 (60)51 (57)0.77
    ACE inhibitors57 (50)19 (63)38 (42)0.05
    Calcium channel blockers20 (18)5 (17)15 (17)1.00
    Lipid-lowering therapy96 (84)23 (77)73 (81)0.64
Laboratory data
    WBC (×1,000/mm3)6.4 ± 2.16.3 ± 2.56.4 ± 2.10.82
    Platelets (×1,000/mm3)237 ± 62208 ± 71244 ± 950.06
    Hemoglobin (g/dl)13.7 ± 2.212.8 ± 3.613.9 ± 2.90.09
    Hematocrit (%)40.5 ± 5.038.2 ± 11.141.5 ± 7.10.06
    Creatinine (g/dl)1.0 ± 0.21.1 ± 0.21.0 ± 0.50.29
Total cholesterol165 ± 41155 ± 43171 ± 460.10
LDL cholesterol95 ± 3691 ± 3796 ± 350.50
HDL cholesterol50 ± 1245 ± 1352 ± 140.02
TRG123 ± 70124 ± 59122 ± 700.89
  • Data are means ± SD and n (%) unless otherwise indicated. CABG, coronary artery bypass graft; CAD, coronary artery disease; CVA, cerebrovascular accident; PTCA, percutaneous transluminal coronary angioplasty; TRG, triglycerides; WBC, white blood cells.